Integra LifeSciences Holdings (IART)
Total asset turnover
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 1,486,360 | 1,506,670 | 1,533,950 | 1,298,690 | 1,461,480 |
| Total assets | US$ in thousands | 3,781,990 | 3,889,760 | 3,782,380 | 3,615,140 | 3,303,240 |
| Total asset turnover | 0.39 | 0.39 | 0.41 | 0.36 | 0.44 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $1,486,360K ÷ $3,781,990K
= 0.39
The total asset turnover of Integra Lifesciences Holdings Corp has been relatively stable over the past five years, ranging from 0.38 to 0.46. The metric measures the company's ability to generate revenue from its assets, indicating the efficiency of asset utilization in generating sales. With a range of 0.38 to 0.46, the company has been able to generate approximately $0.38 to $0.46 in revenue for every dollar of assets held during these years. The consistency in total asset turnover suggests that Integra Lifesciences has maintained a relatively steady level of efficiency in utilizing its assets to drive revenue generation. The metric may indicate that the company is effectively managing its assets to generate sales, although further analysis would be required to fully assess the company's operational performance and asset management strategies.
Peer comparison
Dec 31, 2023